Rituximab: a promising therapy in systemic lupus erythematosus.
about
Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes.Lupus: an overview of the disease and management options.Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLETransient depletion of B cells in young mice results in activation of regulatory T cells that inhibit development of autoimmune disease in adultsFrequency of Th17 CD20+ cells in the peripheral blood of rheumatoid arthritis patients is higher compared to healthy subjects.The many faces of type I interferon in systemic lupus erythematosusEfficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysisBAFF and MyD88 signals promote a lupuslike disease independent of T cells.New treatment strategies for proliferative lupus nephritis: keep children in mind!B cells flying solo.Biologic treatments for systemic rheumatic diseasesInduction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?The initial presentation of systemic lupus erythematosis with aplastic anemia successfully treated with rituximab.Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.Complement-4 deficiency in a child with systemic lupus erythematosus presenting with standard treatment-resistant severe skin lesion.25-year-old man with flank pain, hematuria, and proteinuria.B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid.Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis.Overexpression of the antiapoptotic gene Bfl-1 in B cells from patients with familial systemic lupus erythematosus
P2860
Q33411406-5B14DF78-7A04-43B7-96A7-EFA94EF09EC5Q33838871-8879841A-249F-419B-80CC-0BA982BB85D2Q34638296-4646AF69-94BB-49AE-BAD0-A18DB4862BE0Q35547592-4500DE95-1FB9-4222-AB46-2ED2D5AA5520Q35852020-6A7411E4-B36B-4E69-8DD0-2744D6219931Q35907830-675ED5C5-CDC5-4D6D-8720-FF0BA813EA52Q36040303-4E6FE11D-87BE-432C-868C-2A9A3A48634FQ36219954-63189DCE-D16A-4DC9-9778-0CA45F7FB287Q36229560-082BB1BD-BAC2-40CF-916F-7BA2DD1D281FQ36915693-484DC77E-EDC5-4BAF-846D-2FF480A80555Q37049026-C8976FBB-2E21-4293-B378-9C654D9C2C8BQ37087438-17635895-D074-4DB9-9CBD-5CF34241413CQ37120570-BBE98185-D5AD-4298-A2A4-84D3DA00B581Q37947986-F2053D25-8F83-42EE-83BF-A5F84DB7C3B6Q38175493-7F6D54FC-42A6-43A5-9E6B-054885C0D5CDQ41956499-99DA7D49-FDFA-4720-A377-F4A6833B0219Q41956739-DB94FF0A-D7AF-4896-AA74-6B65AF45171FQ46484331-B72EB8AF-5083-42B8-80B3-C6AC6E0A1444Q54679503-E57C6753-0AC7-49F9-B12C-667BD04644D9Q57078470-A1A146EB-61C2-4082-BBAA-948490FCDD17
P2860
Rituximab: a promising therapy in systemic lupus erythematosus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Rituximab: a promising therapy in systemic lupus erythematosus.
@ast
Rituximab: a promising therapy in systemic lupus erythematosus.
@en
type
label
Rituximab: a promising therapy in systemic lupus erythematosus.
@ast
Rituximab: a promising therapy in systemic lupus erythematosus.
@en
prefLabel
Rituximab: a promising therapy in systemic lupus erythematosus.
@ast
Rituximab: a promising therapy in systemic lupus erythematosus.
@en
P1433
P1476
Rituximab: a promising therapy in systemic lupus erythematosus.
@en
P2093
Akaluck Thatayatikom
Andrew J White
P356
10.1016/J.AUTREV.2005.05.006
P577
2005-06-13T00:00:00Z